Gambaran Trombositosis Terhadap Penyakit Jantung Koroner pada Penderita Diabetes Melitus
Thrombocytosis Profile in Relation to Coronary Heart Disease among Patients with Diabetes Melitus
Keywords:
Coronary Heart Disease, Diabetes Mellitus, ThrombocytosisAbstract
Diabetes mellitus (DM) is a chronic metabolic disease that contributes to the increased incidence of coronary heart disease (CHD). Chronic hyperglycemia can trigger a prothrombotic state and hematological abnormalities such as thrombocytosis. This study aimed to describe the thrombocytosis profile in DM patients based on the occurrence of CHD. This was a descriptive retrospective study using medical records of 160 DM patients at Sultan Agung Islamic Hospital, Semarang. Platelet counts were classified according to WHO and CDC clinical reference values. Data were analyzed using univariate analysis. The results showed that the majority of respondents had normal platelet counts (63.8%), but there was a significant proportion of thrombocytosis at 28.7% (46 patients). Among patients with CHD (29 patients), the occurrence of thrombocytosis was found to be 11.9% (19 patients), while in the non-CHD group, it was 16.9% (27 patients). In conclusion, thrombocytosis is a hematological finding frequently observed in DM patients and is important to consider in clinical evaluation for cardiovascular risk stratification.
References
American Diabetes Association. (2024). Introduction and Methodology: Standards of Care in Diabetes—2024. Diabetes Care, 47(Supplement_1), S1–S4. https://diabetesjournals.org/care/article/47/Supplement_1/S1/153952/Introduction-and-Methodology-Standards-of-Care-in
Asada, Y., Yamashita, A., Sato, Y., & Hatakeyama, K. (2020). Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques. Pathology International, 70(6), 309–322. https://doi.org/10.1111/pin.12921
Braune, S., Küpper, J.-H., & Jung, F. (2020). Effect of Prostanoids on Human Platelet Function: An Overview. International Journal of Molecular Sciences, 21(23). https://doi.org/10.3390/ijms21239020
Cognasse, F., Duchez, A. C., Audoux, E., Ebermeyer, T., Arthaud, C. A., Prier, A., Eyraud, M. A., Mismetti, P., Garraud, O., Bertoletti, L., & Hamzeh-Cognasse, H. (2022). Platelets as Key Factors in Inflammation: Focus on CD40L/CD40. Frontiers in Immunology, 13, 825892. https://doi.org/10.3389/fimmu.2022.825892
Dal Canto, E., Ceriello, A., Rydén, L., Ferrini, M., Hansen, T. B., Schnell, O., Standl, E., & Beulens, J. W. (2019). Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. European Journal of Preventive Cardiology, 26(2_suppl), 25–32. https://doi.org/10.1177/2047487319878371
Lordan, R., Tsoupras, A., & Zabetakis, I. (2021). Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents. Blood Reviews, 45, 100694. https://doi.org/10.1016/j.blre.2020.100694
Martinez Bravo, G., Annarapu, G., Carmona, E., Nawarskas, J., Clark, R., Novelli, E., & Mota Alvidrez, R. I. (2024). Platelets in Thrombosis and Atherosclerosis: A Double-Edged Sword. The American Journal of Pathology, 194(9), 1608–1621. https://doi.org/10.1016/j.ajpath.2024.05.010
Rusnanta, F., & Rohman, M. S. (2021). The prothrombotic predominance in metabolic syndrome: A complex patomechanism. Heart Science Journal, 2(4), 4–9. https://doi.org/10.21776/ub.hsj.2021.002.04.2
Song, L., Zhao, X., Chen1, R., Li1, J., Zhou1, J., Liu1, C., Zhou1, P., Wang1, Y., Chen1, Y., & Hanjun Zhao1* and Hongbing Yan. (2022). Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes. Cardiovascular Diabetology, 21(1) 1–13. https://doi.org/10.1186/s12933-022-01519-3
Suyanto, S., Sukartini, T., Efendi, F., Fauzi, T., Noor, M. A., Amal, A. I., Wahyuningsih, I. S., Sulistyaningsih, D. R., & Khasanah, F. (2024). Relationship between peer group support with foot care behavior among diabetes mellitus patients : an observational study. Healthcare in low-resource Settings. Vol. 12 No. 1 (2024). https://doi.org/10.4081/hls.2024
Wahyuningsih, I. S., Sulistyaningsih, D. R., & Susanto, W. (2024). Improving flipped classroom learning for patients with diabetes mellitus : an exploration into the influence of educational factors. Healthcare in low-resource Settings. Vol 12 No 3.1–20. https://doi.org/10.4081/hls.2024.10353
Wang, L., & Tang, C. (2020). Targeting platelet in atherosclerosis plaque formation: Current knowledge and future perspectives. International Journal of Molecular Sciences, 21(24), 9760. https://doi.org/10.3390/ijms21249760
World Health Organization. (2023). Cardiovascular diseases (CVDs). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
